Abstract:
Malaria remains a major public health problem in Ethiopia, with Plasmodium vivax (P.
vivax) accounting for a substantial proportion of cases. Chloroquine combined with primaquine is the
first-line treatment for uncomplicated P. vivax infection. Periodic therapeutic efficacy monitoring is
essential to ensure the continued effectiveness of this regimen and to inform malaria treatment policy